(Q37415058)

20 August 2017

1 reference

title

Review: renal protection by inhibition of the renin-angiotensin-aldosterone system (English)

1 reference

20 August 2017

Tomas Berl

1

1 reference

20 August 2017

publication date

1 March 2009

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

20 August 2017

published in

1 reference

20 August 2017

volume

10

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

1-8

1 reference

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Dual renin-angiotensin system blockade at optimal doses for proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Additional antiproteinuric effect of ultrahigh dose candesartan: a double-blind, randomized, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

21 January 2018

Oral renin inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

Aliskiren combined with losartan in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309102747

21 January 2018

Identifiers

DOI

10.1177/1470320309102747

1 reference

20 August 2017

1 reference